Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03060980 |
|
Recruitment Status :
Terminated
(Decision by Sponsor)
First Posted : February 23, 2017
Last Update Posted : March 7, 2019
|
Sponsor:
Intarcia Therapeutics
Information provided by (Responsible Party):
Intarcia Therapeutics
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | January 26, 2018 |
| Actual Study Completion Date : | January 26, 2018 |
| Certification/Extension First Submitted : | February 28, 2019 |